

Publisher: Bentham Science Publishers
E-ISSN: 2212-3903|5|1|58-61
ISSN: 1574-8855
Source: Current Drug Therapy, Vol.5, Iss.1, 2010-02, pp. : 58-61
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content


Interferon Alfacon-1: A Novel Interferon for the Treatment of Chronic Hepatitis C
By Alberti A.
BioDrugs, Vol. 12, Iss. 5, 1999-11 ,pp. :





